Potassium and Perphenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Perphenazine (perphenazine). Common drug interactions include creatinine renal clearance decreased among females and cyanosis among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Perphenazine. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

What is Perphenazine?

Perphenazine has active ingredients of perphenazine. It is often used in bipolar i disorder. eHealthMe is studying from 2,712 Perphenazine users. Check the latest studies of Perphenazine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

41 people who take Potassium and Perphenazine together, and have interactions are studied.

Potassium and Perphenazine drug interactions.

What are the common drug interactions of Potassium and Perphenazine, by gender? *:

female:

Creatinine renal clearance decreased
Depressed level of consciousness
Hypotension (abnormally low blood pressure)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Sedation
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Fall
Drug abuse
Dyspnoea (difficult or laboured respiration)
Overdose

male:

Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Hospitalisation
Insomnia (sleeplessness)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Potassium and Perphenazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Confusional state
Diarrhoea
Nausea (feeling of having an urge to vomit)
Vomiting
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

Cellulitis (infection under the skin)
Colon cancer
Injection site mass
Injection site necrosis (death of body tissue at injection site)
Injection site swelling
Pneumonia
Purulent discharge (discharge that contains pus)
Skin hypertrophy (skin cells enlarges)
Tenderness (pain or discomfort when an affected area is touched)

60+:

Constipation
Mobility decreased (ability to move is reduced)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Fall
Drug abuse
Dyspnoea (difficult or laboured respiration)
Overdose
Creatinine renal clearance increased
Urticaria (rash of round, red welts on the skin that itch intensely)
Abdominal discomfort

What are the existing conditions these people have? *

High Blood Pressure: 28 people, 68.29%
Insomnia (sleeplessness): 26 people, 63.41%
Pain: 26 people, 63.41%
Oedema (fluid collection in tissue): 26 people, 63.41%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 25 people, 60.98%
Constipation: 25 people, 60.98%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 25 people, 60.98%
Dementia (madness): 25 people, 60.98%
Fibromyalgia (a long-term condition which causes pain all over the body): 25 people, 60.98%
Gastric Ulcer (stomach ulcer): 25 people, 60.98%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Perphenazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously